GlobeNewsWire
14 Aug 2026, 10:33 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
IBM reported a significant Q2 2026 shortfall in IBM Z performance and associated software stack, specifically in Transaction Processing. — Core product failure and revenue misses in a primary business segment typically lead to significant valuation downgrades.
-0.80IBM admitted that numerous large business deals failed to close on expected timelines because the company 'did not adapt and move quickly enough.' — Admission of operational inefficiency and failure in sales execution suggests structural or competitive weaknesses.
-0.60Law firm Bleichmar Fonti & Auld is investigating IBM for potential securities fraud regarding misrepresentations of new business pace and IBM Z outlook. — Legal investigations and potential class-action lawsuits create overhangs of litigation risk and potential financial settlements.
-0.40Which stocks this story touches
Continue reading
6 related stories
Search tags
The company is facing a securities fraud investigation following a significant stock drop and poor financial performance.
Mentioned in the context of an ongoing securities fraud class action lawsuit.
Mentioned in the context of an ongoing securities fraud class action lawsuit.
Mentioned only as a past legal success for the law firm, not as current news.
Mentioned only as a past legal success for the law firm, not as current news.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
1h ago
